For the Quarter Ending June 2025
North America
• By the fourth week of June 2025, the Vitamin B2 Spot Price in New Jersey has reached USD 39,700 per metric ton and reflected a 0.25% price increase as part of a steadily firming market influenced by stable procurement momentum.
• Why did the price change in July 2025? The Vitamin B2 Spot Price in North America has experienced a minor upward revision in July 2025 due to persistent downstream demand from pharmaceuticals and nutraceuticals. The supplier adjusted priced strategically to maintain product liquidity in the market. Despite smooth production cycles, cautious inventory replenishment strategies influenced the price trajectory.
• Market equilibrium remained intact as manufacturers maintained uninterrupted operations, helping stabilize the Vitamin B2 Production Cost Trend. No major disruptions affected logistics or capacity.
• Balanced inventories across downstream industries such as personal care and medical sectors helped preserve a steady Vitamin B2 Price Forecast, discouraging speculative buying and avoiding sharp volatility.
• Export momentum to Europe remained strong as consistent international demand underpinned a mildly bullish Vitamin B2 Spot Price movement during Q2.
• Procurement strategies reflected confidence, with buyers refraining from overstocking while securing necessary volumes, thereby maintaining orderly inventory movement across the supply chain.
• Vitamin B2 Demand Outlook remained positive, particularly driven by therapeutic product manufacturing, immune-supporting supplements, and parenteral nutrition.
• April 2025 saw a 0.26% price increase, supported by stable production and firm offtake, while lean restocking cycles added marginal upward pressure on prices.
• May 2025 saw continued market firmness as no production halts or freight issues emerged, allowing uninterrupted order fulfilment and confidence in the Vitamin B2 Price Forecast.
• Supplier-side inventory discipline and regular offtake patterns prevented sharp stock fluctuations, keeping the Vitamin B2 Spot Price firmly within a narrow trading band.
Asia Pacific (APAC)
• As of the fourth week of June 2025, the Vitamin B2 Spot Price Ex-Shanghai has reached USD 37,250 per metric ton and marked a 0.27% rise as demand across fortified food and wellness formulations held strong.
• Why did the price change in July 2025? The Vitamin B2 Spot Price in the APAC region saw a minor increase in July 2025, owing to consistent sector-wise procurement and smooth production conditions. This prompted suppliers to cautiously adjust prices while ensuring healthy inventory turnover and maintaining the Vitamin B2 Price Forecast in a firm territory.
• Vitamin B2 Production Cost Trend was stable due to reliable availability of biofermentation feedstocks like glucose and yeast, enabling uninterrupted manufacturing cycles throughout Q2.
• Balanced inventory practices across pharmaceutical and nutraceutical sectors prevented stockpile-driven distortions and helped preserve a steady Vitamin B2 Price Index.
• Export flow from China remained robust, with scheduled dispatches fulfilling global demand without creating supply-side bottlenecks or order backlogs.
• No seasonal disruption was reported, and procurement strategies were executed conservatively, supporting a steady Vitamin B2 Demand Outlook that aligned well with output volumes.
• In April, the Vitamin B2 Spot Price rose by 0.14%, driven by rising preparations for seasonal production cycles, which created healthy tension in a supply-lean environment.
• In May, the continued upward movement of 0.27% reflected consistent domestic consumption, notably in health supplements, as well as well-paced international export orders.
• Suppliers defended margins in June by limiting surplus accumulation, with moderate price hikes mirroring steady procurement rather than speculative activity.
• Personal care and wellness sectors remained active, sustaining base-level demand, while producers opted for just-in-time manufacturing strategies to manage cost and availability, preserving the Vitamin B2 Spot Price within a controlled range.
Europe
• In the fourth week of June 2025, the Vitamin B2 Spot Price in Germany rose to USD 39,070 per metric ton, registering a 0.26% increase backed by routine procurement and firm overseas offers.
• Why did the price change in July 2025? The slight increase in the Vitamin B2 Spot Price in Europe during July 2025 reflected continuity in stable imports and consistent demand from pharmaceutical and fortified food manufacturers, with no disruptions across production or logistics channels influencing the Vitamin B2 Price Forecast modestly upward.
• Vitamin B2 Production Cost Trend remained steady as primary suppliers like China ensured uninterrupted manufacturing cycles, thus reinforcing reliability across the supply chain.
• German buyers practiced disciplined inventory management, aligning stock levels to routine production cycles which stabilized the market and ensured liquidity for Q3 preparation.
• No port or freight delays in Hamburg supported seamless Vitamin B2 inflows, contributing to a low-risk logistics environment that avoided any artificial price inflations.
• The demand base in Germany was anchored by pharmaceuticals, nutraceuticals, and medical nutrition segments, which maintained steady intake, preventing excessive volatility in the Vitamin B2 Price Index.
• April saw a marginal price dip of 0.05%, attributed to the drawdown of Q1 inventory rather than weak demand, with May and June recovering on account of fresh procurement activity.
• The Vitamin B2 Demand Outlook in Europe remained constructive, with no panic buying observed, yet steady reordering continued ahead of scheduled production cycles.
• Export quotations from the U.S. and China remained firm, reinforcing confidence in a stable Vitamin B2 Price Forecast throughout Q2, even as domestic consumption held steady.
• No signs of oversupply or demand contraction were observed in Q2, enabling importers to avoid speculative hoarding and thus ensuring a calm, moderately bullish market trend.
For the Quarter Ending March 2025
North America
The North American Vitamin B2 market showed a slight downward trend in the first quarter of 2025. Prices fell by an average of 1.90% from previous quarter to this quarter. The shift from winter to spring resulted in reduced demand for Vitamin B2 supplements, as consumption of these products generally declines with the onset of warmer weather. Many Riboflavin distributors and suppliers in the region adopted cautious buying strategies.
Most Vitamin B2 buyers focused on clearing old stock instead of placing fresh bulk orders. Some uncertainty in the market also came from tariff adjustments on key pharmaceutical ingredients, which added to procurement delays. Food and beverage manufacturers maintained steady but limited buying, while personal care sectors showed no major spikes in requirements.
Production schedules in nutraceutical and personal care industries moved at a slower pace as companies waited for stronger market cues. Logistics remained stable, with no significant supply concerns. By late March, a few signs of activity returned as downstream sectors prepared for seasonal production. Overall, the market stayed under soft pressure in first quarter of 2025.
Asia Pacific
In the Asia Pacific region, the Vitamin B2 market displayed a steady upward movement in the first quarter of 2025. Prices increased by 2.16% on average between the concluding quarter of 2024 and first quarter of 2025. The market experienced a seasonal production slowdown in APAC region due to the Lunar New Year holidays. This led to tighter supply from major Vitamin B2 suppliers in the region and prompted distributors in of APAC region like India, Indonesia and South Korea to manage inventories carefully.
Riboflavin demand from pharmaceuticals and nutraceuticals remained stable, while the food and beverage sector procured on a need-based approach to sustain their ongoing production cycles. Seasonal transition in Asia Pacific encouraged moderate procurement as Vitamin B2 buyers aimed to secure material ahead of their production cycles. Smooth logistics operations and steady domestic demand in several markets helped keep price levels on a slightly firm note. By the end of March, order volumes improved as buyers looked to restock for the second quarter. The market maintained a balanced tone with the outlook remaining cautiously steady in the first quarter of 2025.
Europe
The European Vitamin B2 market recorded a modest decline during the first quarter of 2025 with the quarterly average price dropped by 3.34% from the previous quarter. This price correction was driven by weak demand from downstream sectors including pharmaceuticals, food and beverages, and nutraceuticals. The transition from colder to milder weather reduced consumption of Vitamin B2 supplements, as seasonal demand typically softens during this time.
Many Vitamin B2 suppliers in countries like Germany and France chose to maintain lean inventory positions and avoided any situation of excess stock. Buying activity stayed limited, with most orders covering immediate needs. Stable supply of Riboflavin from Asia Pacific also contributed to a mildly pressured market tone. Logistics remained uninterrupted and allowed a steady product flow across borders.
Personal care industries and nutraceutical firms moved at a measured pace and waited for clearer end- user demand trends. Toward the end of first quarter, small signs of recovery appeared as companies began scheduling their upcoming production cycles. The market overall remained quiet but balanced and showed a typical first-quarter adjustment pattern.
For the Quarter Ending December 2024
North America
During Q4 2024, Vitamin B2 prices in North America displayed a considerable price decline of -4.21% across the entire quarter. Values fell from $39,700 per MT in November to $37,500 per MT FOB New Jersey in December 2024. The price dynamics emerged from several market factors. Limited inventory positions and enhanced demand from pharmaceutical and nutraceutical industries initially supported higher prices - until the first half.
Port infrastructure constraints at Shanghai and Los Angeles impacted freight rates and lead times, while labour disputes affected East and Gulf Coast operations. Market participants accelerated procurement due to anticipated U.S. tariff changes, maintaining high TEU volumes. December brought a market reversal as domestic suppliers implemented destocking initiatives while export prices softened in the US.
The market followed typical seasonal weakness as the year 2024 ended. Despite the price decline, robust end-user demand persisted throughout the quarter, especially in pharmaceutical and nutraceutical applications. This combination created a complex environment where initial supply constraints and logistical challenges drove prices higher before giving way to more favourable conditions later on.
APAC
In Q4 2024, Vitamin B2 prices in APAC demonstrated volatile market dynamics, rising to $35760 per MT in China during November before declining to $35000 per MT Ex-Shanghai in December 2024. The Chinese Golden Week holiday in October initially paused market activities, with international buyers implementing pre-emptive procurement strategies to maintain supply chain stability. Manufacturers in China leveraged declining freight rates and post-holiday demand from Western markets, favouring sellers post-holiday until first the half of the quarter. December witnessed systematic destocking initiatives across the supply chain, with manufacturers and suppliers strategically adjusting inventory positions. Despite downward price pressure, demand fundamentals remained resilient, with sustained procurement patterns across domestic and international channels.
The price trajectory reflected sophisticated supply-side strategic considerations, creating unique buying opportunities during the market's transitional period and showcasing the APAC region's adaptive market ecosystem.
Europe
In Q4 2024, Vitamin B2 import prices in Germany showed mixed movement, rising to $43,700 per MT in November before declining to $42,450 per MT CFR Hamburg in December. The quarter began with modest price increases in October, driven by surging demand, extended delivery times from Asian suppliers, and persistent port bottlenecks. November saw further price appreciation, primarily due to surging end-user demand and rising prices in China, compelling German buyers to procure at higher costs. The constrained market environment enabled merchants to implement price hikes and maintain stronger profit margins.
However, December brought a notable price decline as European distributors actively reduced inventory levels while Chinese exporters lowered their prices. This created an attractive buying opportunity for the German importers, prompting increased purchases from Asian suppliers. The price moderation reflected strategic inventory management rather than changes in underlying demand patterns.
For the Quarter Ending September 2024
North America
The Vitamin B2 market in North America demonstrated notable momentum during Q3 2024, with the United States manifesting as the key center of market fluctuations. Price negotiations appreciated from $37,350/MT to $38,750/MT FOB New Jersey throughout July to September 2024. The quarter marked a steady 1% enhancement from Q2 2024, suggesting a measured yet persistent market strengthening. This market evolution reflects an intricate interplay of industry variables and broader economic indicators.
Enhanced consumption patterns from domestic nutraceutical and pharmaceutical industries emerged as principal market drivers, while logistical impediments created supply-side pressures. The market exhibited exceptional adaptability despite facing multiple operational challenges, including maritime congestion, heightened shipping expenses, and ongoing distribution network disruptions. The situation was further intensified by price fluctuations in China's market, a dominant Vitamin B2 supplier, generating cascading effects across the American nutraceutical sector.
The steady price strengthening, marked by a $1,400/MT gain across the quarter, reflects robust market fundamentals and sustained developmental impetus. This trajectory resonates with broader regional patterns, demonstrating the North American Vitamin B2 market's inherent stability despite ongoing supply chain impediments. The synthesis of amplified regional demand, worldwide supply mechanics, and logistical hurdles has engineered a sophisticated yet fundamentally robust pricing landscape.
APAC
The Vitamin B2 landscape in Asia-Pacific exhibited remarkable pricing dynamics in Q3 2024, marked by a distinctive upward movement. China's market recorded a slight quarter-over-quarter decline of 1%, yet maintained its position as a regional price benchmark. The market demonstrated notable price progression, with export valuations advancing from $33,600/MT to $34,890/MT Ex Shanghai between July and September 2024.
This market strengthening was supported by diverse operational factors and market fundamentals. Demand dynamics were characterized by consistent procurement from nutraceutical and pharmaceutical industries, while supply elements were influenced by mounting production expenditures, including raw material costs and operational overheads. The confluence of increased production capacity and logistical constraints, especially port bottlenecks, generated supply-demand disparities supporting price appreciation.
Market resilience was evidenced through sustained buyer engagement and consistent order patterns. These demand indicators, combined with operational hurdles including freight expenses and supply chain intricacies, enabled industry participants to sustain healthy margins. China's domestic market remained instrumental in establishing regional price trends, influenced by both international procurement patterns and domestic consumption dynamics. The relationship between production capabilities and logistical impediments reinforced the market's upward trajectory.
Europe
The European Vitamin B2 landscape exhibited significant price movements during Q3 2024, with Germany functioning as the primary indicator of market dynamics. September prices reached USD 42,975/MT CFR Hamburg, reflecting broader market conditions. The quarterly performance showed a 1% improvement from first to second half, demonstrating steady progression. While experiencing an 11% reduction year-over-year, the market displayed resilience with a 1% quarterly improvement.
Market appreciation stemmed from interconnected supply limitations and demand forces. Manufacturing constraints, particularly in Asian production centers, created availability pressures influencing price levels. This was reinforced by sustained demand from pharmaceutical and nutraceutical sectors maintaining consistent procurement activities.
Germany's market trends served as a bellwether for European pricing dynamics, exhibiting clear seasonal patterns and price correlations. Despite operational challenges, the market maintained its upward trajectory, underlining the European Vitamin B2 market's fundamental stability. The convergence of supply restrictions, sectoral demand patterns, and regional market forces cultivated a constructive pricing environment, characterized by sustained development and market equilibrium across Europe.
FAQs
1. What is Vitamin B2 and why is it important in industrial applications?
Vitamin B2, also known as riboflavin, is a water-soluble vitamin essential for energy metabolism and cellular function. In industrial applications, it plays a critical role in the pharmaceutical, nutraceutical, animal feed, and food fortification sectors, where it is used to improve nutritional profiles and support immune and metabolic functions.
2. Which industries drive the global demand for Vitamin B2?
The major demand drivers for Vitamin B2 include the pharmaceutical sector (for injectable formulations and supplements), the animal nutrition industry (for feed premixes), and the food and beverage industry (for vitamin-enriched products). In recent years, rising awareness about preventive health and functional nutrition has also boosted consumption in the wellness and personal care segments.
3. How is Vitamin B2 commonly manufactured?
Commercial production of Vitamin B2 typically involves microbial fermentation using genetically engineered strains of Bacillus subtilis or Ashbya gossypii. These organisms convert carbohydrates like glucose into riboflavin under controlled conditions, ensuring scalability and consistency of quality.
4. What factors influence Vitamin B2 pricing in the global market?
Vitamin B2 prices are shaped by several key factors, including feedstock costs (e.g., glucose, yeast), fermentation yields, production capacity utilization, inventory cycles, and demand fluctuations across end-user industries. Additionally, global trade dynamics, supplier pricing behaviour, and regulatory trends also contribute to price volatility.
5. Are there any emerging trends in the Vitamin B2 market?
Yes. The Vitamin B2 market is witnessing growing demand for clean-label and plant-based formulations, especially in fortified beverages and vegan supplements. Additionally, tighter quality standards and sustainability considerations are influencing procurement strategies, while the role of riboflavin in immunity and metabolic support is expanding its use in newer therapeutic areas.
